Day: August 30, 2025

The mechanisms driving progression from androgen-dependent (hormone-sensitive or castration-sensitive) prostate cancer to CRPC are still largely unclear, although continued androgen receptor signaling, despite depletion of circulating androgens and androgen receptor blockade, is thought by many to be central to the development of CRPC.